# The Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 Inhibitors (cvMOBIUS)

> **NCT04197453** · — · TERMINATED · sponsor: **Amgen** · enrollment: 752 (actual)

## Conditions studied

- ASCVD

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04197453
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2019-12-06
- **Primary completion:** 2020-12-21
- **Final completion:** 2020-12-21
- **Target enrollment:** 752 (ACTUAL)
- **Why stopped:** Sponsor decision
- **Last updated:** 2021-10-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04197453

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04197453, "The Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 Inhibitors (cvMOBIUS)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04197453. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*